- Home
- EKSO vs HSCS Comparison
EKSO vs HSCS Comparison
Compare EKSO & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EKSO | HSCS |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 8.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | EKSO | HSCS |
|---|---|---|
| Price | $5.56 | $2.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.75 | ★ $9.20 |
| AVG Volume (30 Days) | ★ 326.9K | 69.1K |
| Earning Date | 10-28-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,749,000.00 | $8,669.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $54.65 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.73 | $2.01 |
| 52 Week High | $14.97 | $6.47 |
Technical Indicators
Market Signals| Indicator | EKSO | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 57.37 |
| Support Level | $4.56 | $2.16 |
| Resistance Level | $5.09 | $2.92 |
| Average True Range (ATR) | 0.30 | 0.22 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 92.68 | 83.33 |
Price Performance
Historical ComparisonAbout EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.